UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000052925 |
|---|---|
| Receipt number | R000053221 |
| Scientific Title | The prognostic impact of neoadjuvant chemotherapy for resectable/borderline resectable pancreatic cancer in the elderly patients |
| Date of disclosure of the study information | 2023/11/27 |
| Last modified on | 2023/11/27 21:34:43 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The prognostic impact of neoadjuvant chemotherapy for resectable/borderline resectable pancreatic cancer in the elderly patients
Acronym
The prognostic impact of neoadjuvant chemotherapy for resectable/borderline resectable pancreatic cancer in the elderly patients
Scientific Title
The prognostic impact of neoadjuvant chemotherapy for resectable/borderline resectable pancreatic cancer in the elderly patients
Scientific Title:Acronym
The prognostic impact of neoadjuvant chemotherapy for resectable/borderline resectable pancreatic cancer in the elderly patients
Region
| Japan |
Condition
Condition
Pancreatic cancer
Classification by specialty
| Hepato-biliary-pancreatic surgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Evaluate the tolerability of neoadjuvant chemotherapy in the elderly patients of pancreatic cancer
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Relative dose intensity of neoadjuvant chemotherapy
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The patients who experience neoadjuvant chemotherapy for resectable/borderline resectable pancreatic cancer
The patients who do not refuse to participate in this study
Key exclusion criteria
Other patients who are judged by the principal investigator to be unsuitable as research subjects.
Target sample size
35
Research contact person
Name of lead principal investigator
| 1st name | Masaaki |
| Middle name | |
| Last name | Minagawa |
Organization
Juntendo University Hospital
Division name
Hepatobiliary-Pancreatic Surgery
Zip code
113-8421
Address
2-1-1, Hongo, Bunkyo-ku, Tokyo
TEL
03-3813-3111
m-minagawa@juntendo.ac.jp
Public contact
Name of contact person
| 1st name | Masaaki |
| Middle name | |
| Last name | Minagawa |
Organization
Juntendo University Hospital
Division name
Hepatobiliary-Pancreatic Surgery
Zip code
113-8421
Address
2-1-1, Hongo, Bunkyo-ku, Tokyo
TEL
03-3813-3111
Homepage URL
m-minagawa@juntendo.ac.jp
Sponsor or person
Institute
Juntendo University Hospital
Institute
Department
Personal name
Funding Source
Organization
not applicable
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Juntendo University Hospital
Address
2-1-1, Hongo, Bunkyo-ku, Tokyo
Tel
03-3813-3111
m-minagawa@juntendo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 11 | Month | 27 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2021 | Year | 05 | Month | 07 | Day |
Date of IRB
| 2021 | Year | 05 | Month | 07 | Day |
Anticipated trial start date
| 2021 | Year | 05 | Month | 07 | Day |
Last follow-up date
| 2029 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
not allicable
Management information
Registered date
| 2023 | Year | 11 | Month | 27 | Day |
Last modified on
| 2023 | Year | 11 | Month | 27 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053221
